Probi AB (Sweden) Today
| PROB Stock | SEK 351.00 105.00 42.68% |
Performance7 of 100
| Odds Of DistressLess than 9
|
Probi AB is selling for under 351.00 as of the 22nd of November 2024; that is 42.68 percent increase since the beginning of the trading day. The stock's last reported lowest price was 350.0. Probi AB has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Probi AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of December 2022 and ending today, the 22nd of November 2024. Click here to learn more.
Probi AB , a bioengineering company, researches, develops, manufactures, markets, and sells probiotics for food, health, and pharmaceutical companies. The company was founded in 1991 and is headquartered in Lund, Sweden. Probi AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. The company has 11.39 M outstanding shares. More on Probi AB
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Probi Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Probi AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Probi AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Probi AB (PROB) is traded on Stockholm Exchange in Sweden and employs 154 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Probi AB's market, we take the total number of its shares issued and multiply it by Probi AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Probi AB operates under Biotechnology sector and is part of Health Care industry. The entity has 11.39 M outstanding shares.
Probi AB has accumulated about 251.02 M in cash with 154.19 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.7.
Check Probi AB Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Probi AB is kr2.08 Billion. Probi AB holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.6 pct. of Probi AB outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with substantial debt, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
Check Probi Ownership Details
Probi AB Risk Profiles
Although Probi AB's alpha and beta are two of the key measurements used to evaluate Probi AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.7 | |||
| Semi Deviation | 2.62 | |||
| Standard Deviation | 5.95 | |||
| Variance | 35.41 |
Probi Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Probi AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Probi AB Corporate Management
Elected by the shareholders, the Probi AB's board of directors comprises two types of representatives: Probi AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Probi. The board's role is to monitor Probi AB's management team and ensure that shareholders' interests are well served. Probi AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Probi AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Veronica Dong | Head Singapore | Profile | |
| Henrik Lundkvist | Chief Officer | Profile | |
| Andy McShea | Chief Officer | Profile | |
| Basudha BhattaraiJohansson | VP Sustainability | Profile | |
| Tom Ronnlund | Chief Officer | Profile | |
| Niklas Larsson | Lead Affairs | Profile | |
| Magdolna Dimn | Group Controller | Profile |
Additional Tools for Probi Stock Analysis
When running Probi AB's price analysis, check to measure Probi AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Probi AB is operating at the current time. Most of Probi AB's value examination focuses on studying past and present price action to predict the probability of Probi AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Probi AB's price. Additionally, you may evaluate how the addition of Probi AB to your portfolios can decrease your overall portfolio volatility.